Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 5/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | CRHBP | P24387 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | RELA | Q04206 | 1/20 | 0.33 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HTR1D | P28221 | 1/20 | 0.31 |
| ▸ | HTR1B | P28222 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4458076 | 0.87 | CA4 (0.42) | LTA4HCA4CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL20710809 | 0.82 | LTA4H (0.37) | LTA4HCA4NPC1RAB9ATSHR | |
| SCHEMBL11659528 | 0.82 | ACHE (0.38) | TSHRL3MBTL1LMNA | |
| SCHEMBL20710785 | 0.80 | LTA4H (0.35) | LTA4HCA4TSHRRELA | |
| SCHEMBL385592 | 0.78 | LTA4H (0.43) | LTA4HCA4CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL443626 | 0.78 | LTA4H (0.43) | LTA4HCA4CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL20710814 | 0.78 | LTA4H (0.41) | LTA4HTSHRLMNA | |
| SCHEMBL20710833 | 0.77 | DRD2 (0.40) | LTA4HLMNA | |
| SCHEMBL20710773 | 0.77 | RELA (0.45) | NPC1RAB9ARELALMNA | |
| SCHEMBL20710838 | 0.77 | LTA4H (0.42) | LTA4HCA4CHRNB2CHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0376198-A2 | Phosphorus compounds that delay the metathesis polymerization of cycloolefins | HERCULES INCORPORATED (US) | 1990-07-04 | — | — | EP | claimed |
| JP-4368362-A | — | — | None | — | — | JP | disclosed |
| US-20240194875-A1 | GRAPHITE ACTIVE MATERIAL, PREPARATION METHOD THEREFOR, AND HIGH-CAPACITY SECONDARY BATTERY COMPRISING SAME FOR HIGH-SPEED CHARGING AND DISCHARGING | THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC) (KR) | 2024-06-13 | — | — | US | disclosed |
| US-20240136525-A1 | ANODE ACTIVE MATERIAL, AND HIGH-CAPACITY SECONDARY BATTERY FOR FAST CHARGING COMPRISING THE SAME | THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC) (KR) | 2024-04-25 | — | — | US | disclosed |
| WO-2023113253-A1 | ELECTROLYTE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY COMPRISING SAME | 충남대학교 산학협력단 | 2023-06-22 | — | — | WO | disclosed |
| CN-107250202-B | ROMP polymers with improved resistance to hydrocarbon fluids | 马特里亚公司 | 2021-10-01 | — | — | CN | disclosed |
| EP-3356376-B1 | METHOD FOR THE PREPARATION OF PHOSPHINATES | BASF SE (DE) | 2019-08-07 | — | — | EP | disclosed |
| EP-2880041-B1 | PROCESS FOR PREPARATION OF ARYL PHOSPHOROUS COMPOUNDS | COUNCIL SCIENT IND RES (IN) | 2018-10-10 | — | — | EP | disclosed |
| US-9200018-B2 | Process for preparation of aryl phosphorous compounds | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-12-01 | — | — | US | disclosed |
| US-20150210725-A1 | PROCESS FOR PREPARATION OF ARYL PHOSPHOROUS COMPOUNDS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-07-30 | — | — | US | disclosed |
| US-H1388-H | Metathesis polymerizable olefin monomer, procatalyst, procatalyst activator, and at least one of lewis acid catlayst , anionic catalyst, free radical initiator and hydrosilation catalyst | HERCULES INCORPORATED (US) | 1994-12-06 | — | — | US | disclosed |
| US-5208224-A | Phosphorus containing compounds as antihypercholesterolemic and antiatherosclerotic agents | WARNER-LAMBERT COMPANY (US) | 1993-05-04 | — | — | US | disclosed |
| JP-H04368362-A | PRODUCTION OF 1,4-DICYANOBUTENES | MITSUBISHI KASEI CORP | 1992-12-21 | — | — | JP | disclosed |
| EP-0376198-A2 | Phosphorus compounds that delay the metathesis polymerization of cycloolefins | HERCULES INCORPORATED (US) | 1990-07-04 | — | — | EP | disclosed |
| US-4933402-A | Phosphorus compounds that delay the metathesis polymerization of cycloolefins | HERCULES INCORPORATED (US) | 1990-06-12 | — | — | US | disclosed |
| US-4446061-A | FIREPROOFING, SMOKELESS, PHOSPHITE/PHOSPHONATE | MONSANTO COMPANY (US) | 1984-05-01 | — | — | US | disclosed |
| US-4313761-A | FIREPROOFING AND SMOKE SUPPRESSANTS | MONSANTO COMPANY (US) | 1982-02-02 | — | — | US | disclosed |
| US-4260542-A | FLAME RETARDANTS, SMOKE SUPPRESSANTS | MONSANTO COMPANY (US) | 1981-04-07 | — | — | US | disclosed |
| US-4206133-A | FLAME RETARDANTS AND SMOKE SUPPRESSANTS | MONSANTO COMPANY (US) | 1980-06-03 | — | — | US | disclosed |
| US-4133823-A | FIREPROOFING, SMOKELESS | MONSANTO COMPANY (US) | 1979-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150210725-A1 | PROCESS FOR PREPARATION OF ARYL PHOSPHOROUS COMPOUNDS | PFAS, PAICS, INPP5B | LTA4H 4618/4885CA4 488/4885NPC1 1674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.